Digital PCR (dPCR) has emerged as a leading technique for the precise quantification of biologics due to its unmatched sensitivity, precision, and accuracy. At Alta Analytical, we harness the power of the QuantStudio Absolute Q Digital PCR System, ensuring that our clients benefit from state-of-the-art technology known for its reliability and performance. This platform enables us to quantify nucleic acids or target sequences with exceptional sensitivity, a key aspect in maintaining the quality and consistency of biologic products.
Adherence to regulatory standards is paramount. When utilizing dPCR methods for releasing biologics, it's essential to strictly follow regulatory guidelines, validation procedures, and Good Manufacturing Practices (GMP). Given the unique nature of each biologic product and therapeutic approach, specialized method validation and optimization are crucial.
The landscape of biologic release testing is ever-evolving. With continuous advancements in technology and shifting regulatory guidelines, staying informed and aligned with the latest best practices in dPCR application is a commitment we uphold for our clients.
Following our commitment to providing top-tier analytical services, Alta Analytical proudly utilizes the QuantStudio 6 Pro Real-Time PCR System. These state-of-the-art instruments elevate our real-time PCR capabilities, ensuring rapid, precise, and reliable results. The QuantStudio systems are renowned for their advanced optics and intuitive interface, enabling a seamless and efficient workflow. Paired with our team's expertise, this technology ensures that our clients receive accurate and actionable insights from their samples. Whether it's gene expression analysis, genotyping, or any other real-time PCR requirement, trust in Alta Analytical's dedication to quality and innovation.